resiquimod has been researched along with Caliciviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enosi Tuipulotu, D; Lun, JH; Mackenzie, JM; Netzler, NE; White, PA | 1 |
| Abt, MC; Artis, D; Becattini, S; Buffie, CG; Carter, RA; Keith, JW; Leiner, I; Osborne, LC; Pamer, EG; SuĊĦac, B | 1 |
2 other study(ies) available for resiquimod and Caliciviridae Infections
| Article | Year |
|---|---|
TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
Topics: Aminoquinolines; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Guanosine; Humans; Imidazoles; Imiquimod; Mice; Pteridines; RAW 264.7 Cells; Toll-Like Receptor 7; Virus Replication | 2018 |
TLR-7 activation enhances IL-22-mediated colonization resistance against vancomycin-resistant enterococcus.
Topics: Ampicillin; Animals; Caliciviridae Infections; CD11c Antigen; Colony Count, Microbial; Dendritic Cells; Drug Resistance, Bacterial; Enterococcus; Gastroenteritis; Imidazoles; Interferon Type I; Interleukin-1; Interleukin-22; Interleukin-23; Interleukins; Ligands; Mice, Inbred C57BL; Norovirus; Pancreatitis-Associated Proteins; Proteins; Signal Transduction; Toll-Like Receptor 7; Vancomycin | 2016 |